UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  March 1, 2022

 

MITESCO, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

000-53601

 

87-0496850

(State or other jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1600 Highway 100 South, Suite 432

St. Louis Park, MN 55416

(Address of principal executive offices) (Zip Code)

 

(844) 383-8689

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 1, 2022, the Board of Directors appointed Ms. Jessica Finnegan its Vice President of Human Resources.

 

Ms. Finnegan has since 2020 been Vice President of People / CHRO (MKS2 Technologies, Austin, TX, USA.  She led all aspects of human resources for the organization including employees in 49 States and Puerto Rico and was responsible for successfully developing and deploying HR capabilities in the areas of engagement, talent development, performance management and succession planning, organization design, and merger and acquisition.

 

She served in several senior management positions directing Human Resources while at Global Aerospace Logistics, based in Abu Dhabi, UAE from 2010 through 2020. From 2009 thorough 2010 she worked for the US Department of Defense as Senior Manager for HR Operations based at Fort Bragg, NC. Prior to that she was an Officer in the US Army where she rose from Aviation Officer & Pilot to Platoon Leader, Company Commander, Aviation Operations and finally Executive Officer in the Airborne Corps during her 9 years of service.

 

Ms. Finnegan holds a Bachelor of Science Degree focused on Systems Engineering from the United States Military Academy, a Master of Business Administration (MBA) Degree from the University of Massachusetts, Amherst, and is completing a Master of Jurisprudence in Labor & Employment Law Degree at Tulane University Law School. Further, she has a professional accreditation as a Senior Professional in Human Resources International (SPHRi).

 

In connection with her appointment, the Company entered into an employment agreement with Ms. Finnegan (the “Employment Agreement”), effective March 1, 2022 (the “Effective Date”), pursuant to which the Company has agreed to pay M. Finnegan an annual base salary of $225,000, payable in accordance with the Company’s standard payroll procedures. In addition, Ms. Finnegan will be eligible to receive a bonus target of 25% of her base salary, at the sole discretion of the Compensation Committee of the Board. Ms. Finnegan’s base compensation shall accrue until such time as the Company has sufficient funding. Additionally, pursuant to the Employment Agreement, Ms. Finnegan has been awarded options (the “Options”) to purchase up to five hundred thousand shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at an exercise price equal to the closing stock price of our Common Stock on the date the Mitesco, Inc. 2022 Omnibus Securities and Incentive Plan becomes effective. The Options vest pursuant to the following schedule: (a) 125,000 of the Options shall vest upon the 90-day anniversary of the Effective Date, (b) 125,000 of the Options shall vest once the Company (parent and VIEs and subsidiaries) has 130 full-time employees, (c) 125,000 of the Options shall vest on the one-year anniversary of the Effective Date, and (d) 125,000 of the Options shall vest once the Company files an Annual Report on Form 10-K that reports $20 million in gross revenue. Upon a change of control of the Company, any unvested Options shall immediately vest.

 

The Employment Agreement is effective from March 1, 2022 until the earlier of Ms. Finnegan’s resignation or termination by us under the following circumstances (i) a vote of the majority of our directors; (ii) a violation of the securities laws, or (iii) upon her incapacity or inability to perform all the duties set forth in this Agreement due to mental or physical disability. In the event of termination by us, Ms. Finnegan will only be entitled to compensation owed through the date of termination and all Options that have not yet vested will be cancelled. The Employment Agreement also contains customary non-disclosure, non-compete and confidentiality provisions.

 

The description of the Employment Agreement does not purport to be complete, and is qualified in its entirety by reference to the Employment Agreement, which is filed as exhibit 10.1 to this Current Report on Form 8-K.

 

Item 8.01

Other Events.

 

On March 1, 2022, the Company issued a press release announcing its appointment of Ms. Finnegan as its Vice President for Human Resources.

 

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

On Tuesday March 8, 2022 Mitesco’s CEO Mr. Larry Diamond will host a shareholder update call at 4:15 Eastern Time.  To view the PowerPoint and presentation and participate live over the webcast link, please go to:

 

https://www.webcaster4.com/Webcast/Page/2848/44800

 

 

 

If unable to view the webcast, you may participate via teleconference by dialing in five to ten minutes before the call: (Toll Free) 888-506-0062 domestically, or 973-528-0011 internationally. Entry code:  264574.

 

A copy of the press release is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

 

A copy of the presentation is furnished as Exhibit 99.3 to this Current Report on Form 8-K.

 

The information presented in this Item 8.01 of this Current Report on Form 8-K and Exhibit 99.1 is being furnished and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of the Company, under the Securities Act of 1933, or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing. 

 

Item 9.01

Financial Statements and Exhibits.

 

Exhibit No.

 

Description

10.1

 

Employment Agreement for Ms. Finnegan Dated January 12, 2022

99.1   Press Release dated March 1, 2022

99.2

 

Press Release dated March 3, 2022

99.3   Investor Presentation

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MITESCO, INC.

 

 

 

Date: March 3, 2022

By:

/s/ Phillip J. Keller

 

 

 

Phillip J. Keller

 

 

Chief Financial Officer

 

 

 

 
NONE false 0000802257 0000802257 2022-03-01 2022-03-01

Exhibit 10.1

 

logo_1.jpg

 

SENIOR EXECUTIVE EMPLOYMENT AGREEMENT

 

 

This Agreement is made as of the 12th day of January 2022, between the MITESCO, INC. a publicly traded company incorporated in the State of Delaware (“Employer”), and Jessica Finnegan, residing at                                                                    (“Employee”).

 

WHEREAS, the Employer, the authorized representative of the Employer, desires to employ Jessica Finnegan as the Vice President, Human Resources of Mitesco Inc.; and

 

WHEREAS, the parties have reached an agreement as to the terms of said employment as more fully set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the promises and the mutual covenants, terms and conditions as hereinafter set forth, the parties hereby agree as follows:

 

1. Nature of Services and Duties.  

 

a. Effective, not later than, March 1, 2022, Employee shall serve in the position of Vice President, Human Resources of Mitesco Inc.  

 

b. At all times during the term of this Agreement, Employee shall use his/her best efforts and apply his/her skill and experience to the proper performance of his/her duties hereunder and to achieve the goals set forth herein.  Employee shall be directly accountable to and work under the authority and direction of the Chief Executive Officer or any “Designee” the CEO shall direct the Employee to report to, and shall report through such offices as may be directed by the CEO, or their Designee, from time to time.  Employee shall perform such executive, managerial and administrative duties and services as are customary for a Vice President, Human Resources, including without limitation:

 

 

Create and deliver briefings to executives

 

Collaborating with management team to enhance the company’s vision and mission

 

Developing strategic HR plans and policies

 

Oversee an organization’s recruitment, interview, selection, and hiring processes

 

Plan employee benefit, payroll, health and safety programs

 

Establish an effective executive compensation plan and new employment agreements appropiste for a company of our size and stage

 

Serve as the liaison between the PEO and the company and employees on all HR/benefits/payroll related issues.

 

Facilitate and monitor the implementation of standardized human resource processes

 

Adhere to all internal policies and legal standards

 

Enhance systems (e.g. paper-based timesheets, grievance procedures)

 

Defend the organization from inquiries by Unions and Lawyers

 

Effectively structure benefits programs to attract and retain top talent

 

Work with technical team to design, integrate and implement human resource software systems for better efficiency

 

Recommend new and improved measures for performance evaluations

 

Duties as assigned

 

 

844.383.8689

601 Carlson PKWY, Suite 1050 Minnetonka, MN 55305

www.mitescoinc.com

 

 

 

logo_1.jpg

 

 

2. Term.  

 

This Agreement shall be effective from March 1 , 2022, (“the Commencement Date”), or as agreed prior to March 1, 2022, through employees’ resignation, (“the Termination Date”), unless amended by subsequent written agreement of the parties or terminated as provided herein.  The Employee shall be considered a full-time employee as of the Commencement Date.

 

3. Compensation.  

 

(a)Employee shall be paid an annual base salary of Two-Hundred-Twenty-Five Thousand ($225,000) Dollars payable in accordance with the Employer’s standard payroll procedures, with a performance and salary review to be conducted annually, at which time the Employee’s salary shall be adjusted in accordance with applicable compensation policies.

 

(b)In addition, Employee shall be eligible to receive a bonus target of 25% of base compensation commencing fiscal year 2022, if approved by the Compensation Committee in its sole discretion.

 

(c)The Employee agrees that their Compensation will accrue from the Commencement Date of this agreement until such time as the Company, as determined by the Board, has sufficient funding.

 

(d)The Employee may receive certain awards of incentive stock options, and those awards are subject to certain vesting, or conditions, including, but not limited to the tenure of the Employee, or achievement of certain objectives, as more further defined in the award notice and the S8 policy and procedures, and generally under the terms as noted below:

 

1.Award of Incentive Stock Options. 

 

Mitesco, Inc. (the “Company”) hereby Awards incentive Stock Options of the Company pursuant to vesting terms.  The Stock Options are awarded by a authorization of the Board of Directors within 30 business days of employment start date and priced in accordance with the S-8 plan and the plan policies and procedures. Any violations of securities laws, or the provisions of the Code of Conduct will result in the immediate cancellation of any and all stock awards previously issued or authorized.

 

2.Vesting is as follows:

 

a) 125,000 options once the Employee has been with the Employer for 90 days from the effective date of this agreement;

 

b) 125,000 options once the Company (parent and VIEs and subsidiaries) has 130 full-time employees;

 

c) 125,000 options once the Employee has been with the Company for 365 days from the effective date of this agreement;

 

d) 125,000 options once the Employer files a 10K that reports $20,000,000 in Gross Revenue;

 

e) In the event of a change in control of the Company, any remaining unvested shares will immediately vest upon change of control of the Company.

 

3. Restrictions on Transfer.

 

Governed by the Stock Option Plan, S-8 as filed with the SEC

 

4. Termination. 

 

Employee’s employment hereunder may be terminated by Employer under the following circumstances:

 

(a) A vote of the majority of the members of the Board of Directors;

 

(b) Upon any violations of the Securities laws;

 

(c) Upon incapacity or inability to perform all the duties set forth in this Agreement due to mental or physical disability;

 

844.383.8689

601 Carlson PKWY, Suite 1050 Minnetonka, MN 55305

www.mitescoinc.com

 

 

 

logo_1.jpg

 

If Employee’s employment is terminated by virtue of any of the events described in paragraph (a), (b), or (c) Employee shall be entitled only to compensation though the date of such termination and any incentive stock options that have not vested shall be cancelled in accordance with the S-8 plan.

 

5. Confidentiality and Proprietary Information.

 

Employee acknowledges that he/she will be exposed to confidential information of the Employer, which includes confidential information of Mitesco, Inc., and other operations and activities.  Confidential information includes, but is not limited to, data relating to the Employer’s operations, customer information, financial data, computer programs, architectural drawings, marketing plans and information, operating procedures and the like, or any other information of the business affairs of Mitesco.

 

Employee shall not, directly or indirectly, use, disseminate, disclose, or in any way reveal or use beyond the scope of authority granted by the Employer all or any part of such Confidential Information, which he/she has been or will be exposed to, and shall use such Confidential Information only to the extent specifically authorized by the Employer.

 

Upon termination of this Agreement for any reason whatsoever, Employee shall turn over to the Employer all Confidential Information. Employee acknowledges that the Employer may exercise any and all remedies available to it at law or in equity to enforce this Agreement with respect to non-disclosure of any Confidential Information, which Employee has or will become privy to in the performance of its obligations under this Agreement.  The parties acknowledge that this provision shall survive the termination of the Agreement.

 

6. Work Product

 

Any programs, systems, plans, software, hardware, devices, and ideas developed by Employee or anyone in the Employee’s Department during the period of Employee’s employment from the date of original hire shall be the exclusive property of the Employer.

 

7. Covenant Not to Compete.  

 

(a)Employee agrees that during the terms of this Agreement he shall devote his full business time, energy, skill, labor, and attention to the affairs of the Employer and its affiliates or subsidiaries, shall promptly and faithfully do and perform all services pertaining thereto that are or may hereafter be required of him by the Employer, and shall not engage in any activities, directly or indirectly, involving a conflict of interest with the business or relations of the Employer or its affiliates or subsidiaries.

 

(b)Employee recognizes that the business of the Employer and its affiliates or subsidiaries are national and international in scope and that the services to be performed hereunder and the methods employed by the Employer or its affiliates or subsidiaries are such as will place Employee in close business and personal relationship with competing businesses of the Employer or its affiliates or subsidiaries.  Therefore, from and after the date of this Agreement and for one year after expiration of this Agreement or termination of this Agreement, Employee shall not, directly or indirectly, for his own benefit or for, with, or through any other person, company, or competitive company to Employer, within the states of Georgia own, manage consult, or be connected with, as owner, partner, joint venture, director, employee, officer, consultant, or in any other capacity whatsoever, engage in any business which is the same as, similar to or competitive with any business activities of the Employer.  “Business” is defined as any compounding retail pharmacy activity.  Employee acknowledges that the restrictive covenants (the “Restrictive Covenants’) contained in this Section are a condition of his employment and are reasonable and valid in geographical and temporary scope and in all other respects.  If any court determines that any Restrictive Covenants, or any part of the Restrictive Covenants, is invalid or unenforceable, the remainder of the Restrictive Covenants and parts thereof shall not thereby be affected and shall be given full effect, without regard to the invalid portion.  If any court determines that any of the Restrictive Covenants, or any part thereof, is invalid and unenforceable because of geographic or temporal scope of such provision, such court shall have the power to reduce the geographic or

 

844.383.8689

601 Carlson PKWY, Suite 1050 Minnetonka, MN 55305

www.mitescoinc.com

 

 

 

logo_1.jpg

 

temporal scope of such provision, as the case may be, and, in its reduced form, such provision shall then be enforceable.

 

(c) If Employee breaches, or threatens to breach, any of the Restrictive Covenants, the Employer, in addition to and not in lieu of any other rights and remedies it may have at law or in equity, shall have the right to injunctive relief; it being acknowledged and agreed to by Employee that any such breach or threatened breach would cause irreparable and continuing injury to the Employer and that money damages would not provide an adequate remedy to the Employer.

 

8. Miscellaneous.

 

(a) Employee represents to Employer that there are no restrictions or agreements to which he is a party which would be violated by his execution of this Agreement and his employment hereunder.

 

(b) No amendment or waiver of any provision of this Agreement shall be effective unless in writing signed by both parties.

 

(c) Employee shall have no right to assign, transfer, pledge or otherwise encumber any of the rights, nor to delegate any of the duties created by this Agreement.

 

9. Governing Law.

 

This Agreement is subject to and shall be interpreted in accordance with the laws of the State of Delaware.

 

EXECUTED, as of the date first written above.

 

 

 

EMPLOYER

 

Lawrence Diamond

 

 

By: ________________________________

 

Date: ______________________________

 

 

 

EMPLOYEE

 

Jessica Finnegan

 

 

By: ____________________________

 

Date: ______________________________

 

 

844.383.8689

601 Carlson PKWY, Suite 1050 Minnetonka, MN 55305

www.mitescoinc.com

 

Exhibit 99.1

 

Mitesco Appoints Jessica Finnegan to Vice President of Human Resources

 

MINNEAPOLIS, MN, March 1, 2022 - Mitesco, Inc. (OTCQB: MITI), a leading operator of wellness clinics that combine a nurse practitioner model with personalized, whole-person primary care, today announced the appointment of Ms. Jessica Finnegan to the position of Vice President, Human Resources.

 

Ms. Finnegan most recently served as the Vice President of People and Chief Human Resources Officer at MKS2 Technologies, an Austin, Texas-based technology business providing services to the Federal Government and commercial clients. She led all aspects of human resources for the organization, supporting employees in 49 States and Puerto Rico and was responsible for successfully developing and deploying HR capabilities in the areas of engagement, talent development, performance management, succession planning, organization design, and merger & acquisitions.

 

From 2010 through 2020 she served in several senior management positions directing international Human Resources at Global Aerospace Logistics in Abu Dhabi, one of the leading regional providers of integrated aviation readiness solutions for military and civilian customers. From 2009 through 2010 she worked for the US Department of Defense as Senior Manager for Operations based at Fort Bragg, NC. For the nine years prior, she was an Officer in the US Army, where she rose from Junior Aviation Officer and Pilot to Platoon Leader, Company Commander, Aviation Operations Staff Officer and finally, Executive Officer in the XVIII Airborne Corps.

 

Ms. Finnegan holds a Bachelor of Science Degree focused on Systems Engineering from the United States Military Academy, a Master of Business Administration (MBA) Degree from the University of Massachusetts, Amherst, and is completing a Master of Jurisprudence in Labor & Employment Law Degree at Tulane University Law School. Further, she has a professional accreditation as a Senior Professional in Human Resources International (SPHRi).

 

“We are excited to have Jessica join our team,” said Larry Diamond, Mitesco’s CEO. “She has two decades of experience as a military veteran and senior executive global Human Resource leader with confirmed success in delivering complex, multimillion-dollar HR programs. With her strong background in growth situations and proven leadership abilities, we expect her to recruit, train and provide leadership training across our entire organization, including within the community of healthcare professionals for our Good Clinic operations.”

 

“We are proud to have Jessica in our Company and we look forward to a long and successful tenure.”

 

Mr. Diamond added that, as the Company continues to open new clinics at a rapid pace and increase its internal support organization in preparation for a Nasdaq uplisting, Ms. Finnegan will play “an exceptionally vital role” in Mitesco’s growth.

 

 

 

 

 

For additional information on the company, please go to www.mitescoinc.com, which includes an overview, links to research, video interviews with team members and contact information. Mitesco’s most recent filings includes a Form S-1A Registration Statement available for review on the SEC Edgar web site (https://www.sec.gov/ix?doc=/Archives/edgar/data/802257/000118518522000159/miti-20210930.htm ) and all interested parties are encouraged to review the information.

 

About Mitesco, Inc. and The Good Clinic, LLC

Mitesco is building a next-generation healthcare solution, providing healthcare services and technology, to make healthcare more accessible, higher quality, and more affordable. The Mitesco team has extensive experience in building successful growth situations within the healthcare industry, using both organic and acquisition growth strategies. Mitesco embraces that when consumers’ expectations are exceeded the business performance does so as well. Mitesco operations and subsidiaries include The Good Clinic, LLC (“The Good Clinic”) and Acelerar Healthcare Holdings Limited. The Good Clinic (www.thegoodclinic.com) is a wholly owned subsidiary of Mitesco N.A. LLC, the holding company for North American operations. The Good Clinic is building out a network of clinics using the latest telehealth technology with the certified nurse practitioner operating as its primary healthcare provider. The executive team at The Good Clinic includes several of the key executives who brought Minute ClinicTM (previously known as Quickmedix) to scale, which was acquired by CVS in 2006.

 

Contacts:

 

Investor Relations
Jimmy Caplan
512-329-9505
Email: jimmycaplan@me.com

 

Media Relations
Rick Eisenberg
917-691-8934
Email: eiscom@msn.com

 

 

 

Exhibit 99.2

 

Mitesco to Host Shareholder Update Webcast/Conference Call

March 8 at 4:15 p.m. Eastern

 

MINNEAPOLIS, MN, March 3, 2022 - Mitesco, Inc. (OTCQB: MITI), a leading operator of wellness clinics that combine a nurse practitioner model with personalized, whole-person primary care, will host a shareholder update conference call Tuesday, March 8, 2022, at 4:15 p.m. Eastern Time. The call, which will feature a presentation by CEO Larry Diamond of the company’s newly updated investor PowerPoint, will include a discussion of Mitesco’s significant progress on its expansion plans, plans to uplist the company’s common stock to Nasdaq, growth in the activity level of its existing clinics, and other developments. The presentation will be followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below.

 

To view the PowerPoint and presentation and participate live over the webcast link, please go to: https://www.webcaster4.com/Webcast/Page/2848/44800

 

If unable to view the webcast, you may participate via teleconference by dialing in five to ten minutes before the call: (Toll Free) 888-506-0062 domestically, or 973-528-0011 internationally. Entry code: 264574.

 

The teleconference replay will be available shortly after the completion of the live event through 4:15 pm Eastern time on March 22, 2022. You may access the replay by dialing (Toll Free) 877-481-4010 domestically, or 919-882-2331 internationally, and referencing conference ID 44800.

 

You may also access the replay by visiting the company's web site: www.mitescoinc.com. The site also includes a company overview, links to research, video interviews with management, and contact information.

 

“There is a Form S-1A Registration Statement filed and available for review on the SEC Edgar web site (https://www.sec.gov/ix?doc=/Archives/edgar/data/802257/000118518522000159/miti-20210930.htm), and I encourage all interested parties to review the information prior to this call,” said Mr. Diamond. “Further, we will be attending a number of investor conferences in the near-term, and through press releases will continue to update our shareholders on new developments as they occur.”

 

About Mitesco, Inc. and The Good Clinic, LLC

Mitesco is building a next-generation healthcare solution, providing healthcare services and technology, to make healthcare more accessible, higher quality, and more affordable. The Mitesco team has extensive experience in building successful growth situations within the healthcare industry, using both organic and acquisition growth strategies. Mitesco embraces that when consumers’ expectations are exceeded the business performance does so as well. Mitesco operations and subsidiaries include The Good Clinic, LLC (“The Good Clinic”) and Acelerar Healthcare Holdings Limited. The Good Clinic (www.thegoodclinic.com) is a wholly owned subsidiary of Mitesco N.A. LLC, the holding company for North American operations. The Good Clinic is building out a network of clinics using the latest telehealth technology with the certified nurse practitioner operating as its primary healthcare provider. The executive team at The Good Clinic includes several of the key executives who brought Minute ClinicTM (previously known as Quickmedix) to scale, which was acquired by CVS in 2006.

 

Contacts:

 

Investor Relations
Jimmy Caplan
512-329-9505
Email: jimmycaplan@me.com

 

Media Relations
Rick Eisenberg
917-691-8934
Email: eiscom@msn.com

 

 

 

Exhibit 99.3

 

 

 

ex99-3pg_01.jpg

 

 

 

 
ex99-3pg_02.jpg

 

 

 
ex99-3pg_03.jpg

 

 

 
ex99-3pg_04.jpg

 

 

 
ex99-3pg_05.jpg

 

 

 
ex99-3pg_06.jpg

 

 

 
ex99-3pg_07.jpg

 

 

 
ex99-3pg_08.jpg

 

 

 
ex99-3pg_09.jpg

 

 

 
ex99-3pg_10.jpg

 

 

 
ex99-3pg_11.jpg

 

 

 
ex99-3pg_12.jpg

 

 

 
ex99-3pg_13.jpg

 

 

 
ex99-3pg_14.jpg

 

 

 
ex99-3pg_15.jpg

 

 

 
ex99-3pg_16.jpg

 

 

 
ex99-3pg_17.jpg

 

 

 
ex99-3pg_18.jpg

 

 

 
ex99-3pg_19.jpg